Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NOL4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZBED1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | WFDC10B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | BUB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CAMSAP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | YEATS2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | HMGN5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PDCD7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | DCLRE1A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | VBP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |